B. Zhang, B. Xu, R. Zhang, B. Gong, J. Guo. Dysregulated interleukin networks drive immune heterogeneity in Alzheimer’s disease: an immunogenomic approach to subgroup classification and predictive modeling. BMC Neurol 2025; 25(1): 154.

M. Jorfi, A. Maaser-Hecker, R. E. Tanzi. The neuroimmune axis of Alzheimer’s disease. Genome Med 2023; 15(1): 6.

M. S. Uddin, M. T. Kabir, M. Jalouli, M. A. Rahman, P. Jeandet, T. Behl. Neuroinflammatory signaling in the pathogenesis of Alzheimer’s Disease. Curr Neuropharmacol 2022; 20(1): 126-146.

H. M. Blevins, Y. Xu, S. Biby, S. Zhang. The NLRP3 inflammasome pathway: a review of mechanisms and inhibitors for the treatment of inflammatory diseases. Front Aging Neurosci 2022; 14: 879021.

D. V. Brito, F. Esteves, A. T. Rajado, N. Silva, I. Araújo, J. Bragança. Assessing cognitive decline in the aging brain: lessons from rodent and human studies. NPJ Aging 2023; 9(1): 23.

C. N. Byrns, A. E. Perlegos, K. N. Miller, Z. Jin, F. R. Carranza, P. Manchandra. Senescent glia link mitochondrial dysfunction and lipid accumulation. Nature 2024; 630(8016): 475-483.

V. Calabrese, C. Cornelius, A. M. Stella, E. J. Calabrese. Cellular stress responses, mitostress and carnitine insufficiencies as critical determinants in aging and neurodegenerative disorders: role of hormesis and vitagenes. Neurochem Res 2010; 35(12): 1880-1915.

L. D. Cassidy, M. Narita. Autophagy at the intersection of aging, senescence, and cancer. Mol Oncol 2022; 16(18): 3259-3275.

S. Chaib, T. Tchkonia, J. L. Kirkland. Cellular senescence and senolytics: the path to the clinic. Nat Med 2022; 28(8): 1556-1568.

C. H. van Dyck, C. J. Swanson, P. Aisen, R. J. Bateman, C. Chen, M. Gee. Lecanemab in Early Alzheimer’s Disease. N Engl J Med 2023; 388(1): 9-21.

J. R. Sims, J. A. Zimmer, C. D. Evans, M. Lu, P. Ardayfio, J. Sparks. Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 2023; 330(6): 512-527.

M. Fang, J. Hu, J. Weiss, D. S. Knopman, M. Albert, B. G. Windham. Lifetime risk and projected burden of dementia. Nat Med 2025; 31(3): 772-776.

S. Long, C. Benoist, W. Weidner. World Alzheimer Report 2023 reducing dementia risk: never too early, never too late. Alzheimer’s Dis Int 2023; : 11-12.

H. S. Yang, L. Teng, D. Kang, V. Menon, T. Ge, H. K. Finucane. Cell-type-specific Alzheimer’s disease polygenic risk scores are associated with distinct disease processes in Alzheimer’s disease. Nat Commun 2023; 14(1): 7659.

B. M. Bettcher, M. G. Tansey, G. Dorothée, M. T. Heneka. Peripheral and central immune system crosstalk in Alzheimer disease - a research prospectus. Nat Rev Neurol 2021; 17(11): 689-701.

H. Holstege, M. Hulsman, C. Charbonnier, B. Grenier-Boley, O. Quenez, D. Grozeva. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer’s disease. Nat Genet 2022; 54(12): 1786-1794.

I. de Rojas, S. Moreno-Grau, N. Tesi, B. Grenier-Boley, V. Andrade, I. E. Jansen. Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores. Nat Commun 2021; 12(1): 3417.

Q. Behfar, A. Ramirez Zuniga, P. V. Martino-Adami. Aging, Senescence, and Dementia. J Prev Alzheimers Dis 2022; 9(3): 523-531.

S. Verma. Connecting the Dots: Gender, Sexuality, and Societal Influences on Cognitive Aging and Alzheimer’s Disease. Curr Aging Sci 2024; 14:

S. J. Andrews, A. E. Renton, B. Fulton-Howard, A. Podlesny-Drabiniok, E. Marcora, A. M. Goate. The complex genetic architecture of Alzheimer’s disease: novel insights and future directions. EBioMedicine 2023; 90: 104511.

J. I. Wood, E. Wong, R. Joghee, A. Balbaa, K. S. Vitanova, K. M. Stringer. Plaque contact and unimpaired Trem2 is required for the microglial response to amyloid pathology. Cell Rep 2022; 41(8): 111686.

D. Boche, M. N. Gordon. Diversity of transcriptomic microglial phenotypes in aging and Alzheimer’s disease. Alzheimers Dement 2022; 18(2): 360-376.

G. Livingston, J. Huntley, A. Sommerlad, D. Ames, C. Ballard, S. Banerjee. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020; 396(10248): 413-446.

. World Population Ageing 2020 Highlights. 2020; :

C. R. Jr. Jack, D. S. Knopman, S. D. Weigand, H. J. Wiste, P. Vemuri, V. Lowe. An operational approach to National Institute on Aging-Alzheimer’s Association criteria for preclinical Alzheimer disease. Ann Neurol 2012; 71(6): 765-775.

M. M. Mielke, M. M. Machulda, C. E. Hagen, K. K. Edwards, R. O. Roberts, V. S. Pankratz. Performance of the CogState computerized battery in the Mayo Clinic Study on Aging. Alzheimers Dement 2015; 11(11): 1367-1376.

. Global status report on the public health response to dementia. 2023; :

X. Taylor, I. M. Clark, G. J. Fitzgerald, H. Oluoch, J. T. Hole, R. B. DeMattos. Amyloid-β (Aβ) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer’s disease mice. Mol Neurodegener 2023; 18(1): 59.

H. Cai. Systemic inflammatory markers in ageing, Alzheimer’s Disease and other dementias. Brain 2024; awae230:

R. Sengoku. Aging and Alzheimer’s disease pathology. Neuropathology 2020; 40(1): 22-29.

M. A. Beydoun, J. Weiss, S. Banerjee, H. A. Beydoun, N. Noren Hooten, M. K. Evans. Race, polygenic risk and their association with incident dementia among older US adults. Brain Commun 2022; 4(6): fcac317.

X. Li, X. Feng, X. Sun, N. Hou, F. Han, Y. Liu. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990-2019. Front Aging Neurosci 2022; 14: 937486.